Are you taking an integrated approach?
Abuse Liability Assessment of New Drugs: Core Preclinical Studies to Address Regulatory Requirements
Preclinical evaluations of the abuse potential of new drugs affecting the Central Nervous System (CNS) are an integral component of new drug applications.
This informative webinar will present practical and methodological approaches to preclinical assessment of liability testing of novel CNS-active candidates in light of International Regulatory Agencies recommendations. A number of critical parameters that should be carefully considered when designing animal behavioural studies to investigate the abuse potential of novel compounds will be discussed.
Key discussion points of the webinar:
- Regulatory requirements: preclinical species, test doses, behavioural test designs, test conditions, comparators
- Core preclinical studies - methods and examples
About the Speakers
If the video has not loaded above, please click here.